1. Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy
   Dorota Danielak et al, 2018, Expert Opinion on Pharmacotherapy CrossRef
2. Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target
   Marta Reina-Couto et al, 2022, Frontiers in Physiology CrossRef
3. The Relationship Between the Level of Serum ESM‐1 and Lp‐PLA2 in Patients With Acute ST‐Segment Elevation Myocardial Infarction
   Peng Wei et al, 2021, Clinical and Translational Science CrossRef
4. ICAM-1 and CRP as biomarkers of 3-month outcome in acute ischaemic stroke
   Gulnora Sattarovna Rakhimbaeva et al, 2023, BMJ Neurology Open CrossRef
5. The relationship between systemic inflammation index, systemic immune-inflammatory index, and inflammatory prognostic index and 90-day outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
   Fei Ma et al, 2023, Journal of Neuroinflammation CrossRef
6. Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era
   Kunal Mahajan et al, 2020, Indian Heart Journal CrossRef
7. Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases
   João Bessa et al, 2020, Clinica Chimica Acta CrossRef
8. The role of platelet P2Y12 receptors in inflammation
   William A. E. Parker et al, 2024, British Journal of Pharmacology CrossRef
9. Increased Systemic Immune-Inflammation Index Predicts Disease Severity and Functional Outcome in Acute Ischemic Stroke Patients
   Lu Huang, 2022, The Neurologist CrossRef
10. Alterações Precoces nas Interleucinas Circulantes e no Risco Inflamatório Residual após Infarto Agudo do Miocárdio
    Maria E. R. Coste et al, 2020, Arquivos Brasileiros de Cardiologia CrossRef
11. Ticagrelor and Infection Risk in Patients with Coronary Artery Disease
    Lourdes Vicent et al, 2021, Cardiology CrossRef
12. Association between Endothelial Cell-Specific Molecule 1 and Galectin-3 in Patients with ST-Segment Elevation Myocardial Infarction: A Pilot Study
    Peng Wei et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
13. No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction
    Alejandro Diego‐Nieto et al, 2018, Journal of the American Heart Association CrossRef